Dr. Mackey's current research interests and projects include: virtual reality and real-time fMRI; applications of real-time fMRI Phase II; cortical restructuring in patients with chronic pain; cognitive load and perceived pain intensity; fMRI of the Human Cervical Spine; neurotoxins based therapies in chronic pain; intravenous lidocaine in neuropathic pain; outcome assessment in chronic pain; opiate induced hyperalgesia.

Dr. Yang's research interests are in the areas of biomaterials, implant devices, drug delivery, and musculoskeletal tissue engineering.

Dr. Melosh's research is focused on developing methods to detect and control chemical processes on the nanoscale, to create materials that are responsive to their local environment.

Dr. Stevenson's research is focused on the study of the ontogeny and control of heme catabolism and bilirubin production in the developing neonate.

Dr. Sattely uses a multidisciplinary approach combining chemistry, enzymology, genetics, and metabolomics to tackle problems that include new methods for delignification of lignocellulosic biomass and the engineering of plant antibiotic biosynthesis.

Dr. Shah's lab develops methods to annotate, index and analyze large unstructured datasets for enabling use cases of the learning health system.

Dr. Robertson teaches Critical Analytical Thinking and Frontiers in Interdisciplinary Biosciences at Stanford.

Dr. Krams's lab's recent studies have challenged the paradigm that NK cells are not active participants in outcomes after solid organ transplantation.

A major goal of Dr. Malenka's laboratory is to elucidate both the specific molecular events that are responsible for the triggering of these various forms of synaptic plasticity and the exact modifications in synaptic proteins that are responsible for the observed, long-lasting changes in synaptic efficacy.

One of the primary interests of the Porteus lab group is to develop homologous recombination as a method of gene therapy for genetic diseases.